The Food and Drug Administration (FDA) has reported that Hexabrix (ioxaglate meglumine, ioxaglate sodium; Guerbet LLC), a medical imaging agent. Hexabrix is a radiopaque contrast medium indicated for ...
Bracco Diagnostics announced that the Food and Drug Administration (FDA) has approved E-Z-HD (barium sulfate) for oral suspension for use in double-contrast radiographic examinations of the esophagus, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results